Universe Pharmaceuticals Inc (UPC) — Cash Flow-to-Debt Ratio
Universe Pharmaceuticals Inc (UPC) has a Cash Flow-to-Debt Ratio of -0.58x as of December 2025, meaning its operating cash flow of $-7.61 Million could theoretically repay -1% of its total liabilities ($13.17 Million) in one year. See UPC financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Universe Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Universe Pharmaceuticals Inc across 8 annual periods. For the full cash flow conversion analysis, see UPC cash flow metrics.
Annual Cash Flow-to-Debt Ratio for Universe Pharmaceuticals Inc (2018–2025)
Year-by-year debt coverage analysis for Universe Pharmaceuticals Inc. Check UPC operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.38x | $-5.05 Million | $13.17 Million | ▲ +9.4% |
| 2024 | -0.42x | $-9.51 Million | $22.45 Million | ▼ -620.0% |
| 2023 | 0.08x | $1.12 Million | $13.75 Million | ▲ +181.3% |
| 2022 | -0.10x | $-1.31 Million | $13.10 Million | ▲ +45.4% |
| 2021 | -0.18x | $-2.06 Million | $11.21 Million | ▼ -124.0% |
| 2020 | 0.76x | $6.12 Million | $8.00 Million | ▼ -68.4% |
| 2019 | 2.42x | $13.20 Million | $5.45 Million | ▲ +899.8% |
| 2018 | 0.24x | $4.46 Million | $18.40 Million | — |